In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
23 authors.
Yafei DuInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0000-0003-3926-8461 Wenjing WangInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0000-0003-0408-6764 Hui Chin GohInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.
Thamil Selvan VaiyapuriInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0009-0003-6626-4519 Anandhkumar RajuInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0009-0002-0389-9384 Yu-Chun HsiaoCenter for Molecular Medicine, Research Center for Cancer Biology, and Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Cheng Chun WangInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0009-0002-2960-7562 Vanisha AgrawalInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0009-0009-3803-2255 Noorul Farzana MohideenInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.
Norhidayah Binte Mohd MazianInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0009-0000-1398-270X Feride KaratekinInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0009-0009-5430-429X Wendy Kehan WangInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.
Manikandan LakshmananInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0000-0001-5103-3054 Komal GuptaInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.
Han ChangSchool of Medicine, China Medical University, Taichung, Taiwan.
Xavier Le GuezennecInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0000-0002-1590-1325 Frederic BardInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0000-0002-3783-4805 Daniel S W TanNational Cancer Centre Singapore, 11 Hospital Crescent, Singapore 169610, Singapore.
Vinay TergaonkarInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0000-0001-9009-0844 Mien-Chie HungCenter for Molecular Medicine, Research Center for Cancer Biology, and Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.ORCID 0000-0003-4317-4740 Wanjin HongInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0000-0002-1719-8960 Gandhi T K BoopathyInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.ORCID 0000-0002-1821-9540 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Activating mutations in the epidermal growth factor receptor (
Indexed as
Carcinoma, Non-Small-Cell LungIntegrin beta1Lung NeoplasmsMutationReceptors, Purinergic P2Y2Adenosine TriphosphateCell Line, TumorErbB ReceptorsGene Expression Regulation, NeoplasticGenetic TestingHumansPhosphorylationRNA InterferenceSignal TransductionAdenosine TriphosphateEGFR protein, humanErbB ReceptorsIntegrin beta1P2RY2 protein, humanReceptors, Purinergic P2Y2
Identifiers
PMID41564171
PMCPMC12822653
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390